Cerebral Microcirculatory Responses of Insulin-Resistant Rats are Preserved to Physiological and Pharmacological Stimuli by Institóris, Ádám et al.
Cerebral Microcirculatory Responses of Insulin-Resistant
Rats are Preserved to Physiological and Pharmacological
Stimuli
ADAM INSTITORIS,*,†,1 LAURA LENTI,*,†,1 FERENC DOMOKI,† EDINA WAPPLER,‡ TAMA´S GA´SPA´R,†
PRASAD V. KATAKAM,*,‡ FERENC BARI,§ AND DAVID W. BUSIJA*,‡
*Department of Physiology and Pharmacology, Wake Forest University Health Sciences, Winston-Salem, North Carolina, USA; †Department of
Physiology, School of Medicine, University of Szeged, Szeged, Hungary; ‡Department of Pharmacology, School of Medicine, Tulane University, New
Orleans, Louisiana, USA; §Department of Medical Informatics and Medical Physics, School of Medicine, University of Szeged, Szeged, Hungary
Address for correspondence: Adam Institoris, M.D., Ph.D., Department of Physiology, Faculty of Medicine, University of Szeged, Dom ter 10, Szeged H-
6720, Hungary. E-mail: instiadam@gmail.com
1These authors contributed equally to the manuscript.
Received 30 January 2012; accepted 23 July 2012.
ABSTRACT
Objective: Previously, we have shown that IR impairs the vascular
reactivity of the major cerebral arteries of ZO rats prior to the
occurrence of Type-II diabetes mellitus. However, the functional
state of the microcirculation in the cerebral cortex is still being
explored.
Methods: We tested the local CoBF responses of 11–13-week-old
ZO (n = 31) and control ZL (n = 32) rats to several stimuli
measured by LDF using a closed cranial window setup.
Results: The topical application of 1–100 lM bradykinin elicited
the same degree of CoBF elevation in both ZL and ZO groups. There
was no significant difference in the incidence, latency, and
amplitude of the NMDA-induced CSD-related hyperemia between
the ZO and ZL groups. Hypercapnic CoBF response to 5% carbon-
dioxide ventilation did not significantly change in the ZO compared
with the ZL. Topical bicuculline-induced cortical seizure was
accompanied by the same increase of CoBF in both the ZO and
ZL at all bicuculline doses.
Conclusions: CoBF responses of the microcirculation are pre-
served in the early period of the metabolic syndrome, which creates
an opportunity for intervention to prevent and restore the function
of the major cerebral vascular beds.
Key words: Zucker obese, cortical spreading depression, N-methyl-
D-aspartate, bicuculline, hypercapnia
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analysis of variance; CoBF, cortical blood flow; COX-1, cyclooxygen-
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2+-dependent K+; KATP, ATP-sensitive K
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laser Doppler flowmetry; L-NAME, L-nitro-arginine methyl ester;
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NO, nitric oxide; ROS, reactive oxygen species; SEM, standard error of
the mean; ZL, Zucker lean; ZO, Zucker obese.
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INTRODUCTION
IR is a hallmark feature of the metabolic syndrome that is
one of the most serious risk factors for cardiovascular and
cerebrovascular diseases affecting 24 million people in the
United States [10]. Several clinical studies have reported
increased prevalence of acute myocardial infarction and
ischemic stroke in patients with metabolic syndrome and
Type-II diabetes [26,44,56,57]. IR is known to initiate
detrimental changes in many vascular beds well before
plasma glucose levels increase into the range to meet the
diagnostic criteria of Type-II diabetes. Thus, appropriate
animal models need to be used to mimic this important stage
of the metabolic syndrome. In rats, IR can be induced with
fructose feeding [15,34], but a more widely used and
accepted model of metabolic syndrome is the homozygous
leptin receptor-deficient ZO rat. At the age of 11–13 weeks,
these ZO animals are “pre-diabetic,” characterized by IR,
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elevated plasma cholesterol, and triglyceride levels, but
with normal blood pressure and glucose levels as shown
previously in our laboratory [17]. The ZL strain, which is
heterozygous for the mutation, has normal physiological
parameters and can be used as a control group.
Using these animal models, numerous biochemical and
molecular changes in the vasculature were shown to be
associated with IR. Vascular dysfunction of coronary arteries
[33], mesenteric arteries [59], skeletal muscle arteries [28],
and major cerebral arteries [9] has all been described
previously. The quantitative measurement of multiple organ
blood flow showed that several tissues (adiposal tissue,
intestine, and kidney) had a reduced blood flow in a special
type of ZO strain, the Zucker diabetic fatty rats, whereas
baseline cerebral perfusion remained normal even at a
progressive diabetic stage [54]. Stepp et al. measured internal
carotid blood flow with ultrasonic flowmetry in 13–15-week-
old ZO and ZL rats and found similar blood flow values [55].
However, earlier works from our laboratory have described
abnormal vascular functioning focusing mainly on the large
arteries of the cerebral vasculature. Major cerebral arteries of
ZO/fructose-fed rats in the pre-diabetic period showed
reduced endothelium-dependent and -independent relax-
ations to various stimuli under both in vivo and ex vivo
conditions [13–15,17]. In contrast, the constrictor responses
of the basilar artery were found to be either unaffected or
augmented in these animals [16]. The abnormal reactivity of
main cerebral vessels is worsened in the 17-week-old diabetic
ZO rat [48]. The observed vascular dysfunction of the
cerebral arteries probably contributes to the higher vulner-
ability of ZO animals to both ischemic [46] and hemorrhagic
stroke [32]. Despite the thorough investigation of IR-
induced dysfunction of the major cerebral arteries, little is
known about the effect of IR on microvascular reactivity at
the level of the local cortical microcirculation in both pre-
diabetic and diabetic stages. Interestingly, the endothelium-
independent CSD-induced hyperemia was found to be
unaltered in fructose-fed diabetic rats, indicating that
cerebrovascular dysfunction may be limited to specific
vasodilatory mechanisms [52]. As baseline cerebral blood
flow is preserved in IR but the reactivity of major cerebral
arteries is impaired when stimulated, in the present study, we
examined local cortical microvascular reactivity to various
physiological and pharmacological stimuli, which increase
cortical perfusion via multiple, independent signaling path-
ways to detect early microvascular dysfunction in IR using
ZO rats. We also entertained the possibility that restricted
dilation of larger arteries might not interfere with total CoBF
responses to dilator stimuli. In an earlier study in dogs, we
found that fixation of surface arteries at a constant diameter
with cyanoacrylate glue did not reduce resting CoBF or CoBF
responses to arterial hypercapnia measured with radioactive
microspheres [8].
Therefore, we tested the effect of the following: (1)
bradykinin, (2) NMDA, (3) hypercapnia (5% CO2), and (4)
bicuculline (GABAA-type receptor blocker) on CoBF changes
measured with LDF. Bradykinin and hypercapnia have direct
effects on cerebral resistance blood vessels, whereas NMDA
and bicuculline have vascular effects secondary to neuronal
activity (NMDA directly increases neuronal activity, whereas
bicuculline indirectly increases neuronal activity by removing
inhibitory influences). LDF has been shown to be a valid
indicator of changes in CoBF, but as with all methods used to
characterize cerebral vascular responses, it has some limita-
tions that need to be considered in the interpretation of the
results.
MATERIALS AND METHODS
Surgery
Male ZL (n = 32, 11–12 weeks old, body weight=346±42g)
and ZO (n = 31, 11–12 weeks old, body weight=536±43g)
rats were used for the experiments. Animals were maintained
and used in compliance with the principles set forth by the
Animal Care and Use Committee of Wake Forest University
Health Sciences. The surgery and cranial window preparation
were carried out as described previously [37]. In a previous
unpublished study with ad libitum overnight food access, the
blood sugar level for ZO rats (n = 11; body
weight = 516 ± 35 g) was 179 ± 48 mg/dL and for ZL rats
(n = 10; body weight = 321 ± 28), it was 124 ± 57 mg/dL
(mean ± SD). For rats with six hours of fasting, the average
blood sugar level for ZO was 121 ± 31 mg/dL, and for ZL
rats, it was 115 ± 32 mg/dL (mean + SD). Glycated hemo-
globin (HbA1C) levels were 4.5 ± 0.3% in ZL and
5.3 ± 0.5% in ZO animals (A1CNow+®, Bayer, Sunnyvale,
CA, USA). Anesthesia was induced with i.p. administration
of pentobarbital (80 mg/kg) and maintained by an infusion
pump (20 mg/kg/h) via a catheter introduced into the
femoral vein. The rats were mechanically ventilated with
room air supplemented with O2. The end-tidal CO2 level was
continuously monitored with a capnograph (Micro-
Capnometer; Columbus Instruments, Columbus, OH,
USA) and ventilation was adjusted to maintain 40 mmHg
end-tidal CO2 tension. A catheter was introduced into the
femoral artery to obtain blood samples for blood gas
measurements (see Results) and to monitor and keep the
MABP within the physiological range (ZL rats = 84 ± 5 mmHg;
ZO rats = 95±4 mmHg; mean ± SEM). Body temperature was
monitored by a rectal probe and maintained at 37°C by a
water-circulating heating pad. The head of the animal was
fixed in a stereotaxic frame, the skin of the scalp was
retracted, and a 4-mm diameter circular craniotomy was
prepared on the right parietal bone. The brain surface was
continuously moisturized with aCSF (composition in mg/L:
220 KCl, 7714 NaCl, 665 dextrose, 251.4 CaCl2, 61.9 MgCl2,
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and 2066.6 NaHCO3). The dura mater was carefully dissected
and a circular 2-mm high bone wax rim was mounted
around the craniotomy, which was strengthened with
cyanoacrylate. Inflow and outflow ports were inserted into
the rim to enable flushing of the brain and administration of
drugs onto the brain surface. To verify the DC potential shift
during CSD, an Ag/AgCl electrode was positioned over the
dura mater through a burr hole 2 mm rostral to the cranial
window. In animals where EEG was measured instead of DC
potential to prove bicucculine-induced seizure activity, a
second Ag/AgCl electrode was placed onto the cortical
surface under the cranial window through the outflow port.
The ground lead was inserted under the skin of the neck. The
electrodes were connected to an AC–DC amplifier (DAM 50,
differential amplifier; World Precision Instruments, Sarasota,
FL, USA) for the recording of DC potential changes or EEG
signals (AC mode, 100 Hz filter), respectively. A laser
Doppler probe (Periflux 4001 master; Perimed, Stockholm,
Sweden) was placed above the parietal cortex (lambda 3 mm,
bregma 4 mm) to measure CoBF. The window was closed
with a Parafilm® foil and filled with aCSF. In those animals
in which we expected CSD appearance and propagation
following NMDA application, a second laser Doppler probe
was placed 8 ± 1 mm rostral to the first one. CoBF, DC
potential or EEG, MABP, and end-tidal CO2 were contin-
uously recorded and stored on a personal computer with the
IOX software (EMKA Technologies, Falls Church, VA, USA).
After filling and washing the window with aCSF and also
before each stimulus, we recorded eight minutes CoBF
baseline. At the end of the experiments, biological zero of the
laser-Doppler signal was measured following over-anesthesia
and i.v. saturated KCl injection.
Data Analysis
The biological zero values were subtracted from the recorded
data, were averaged for every minute, and were normalized
to the respective averaged baseline values. The CoBF data
were then expressed as the percentage change from baseline
and the maximal CoBF response occurring over a one-
minute interval was determined. When CSDs occurred
(during NMDA applications), the maximal increase in the
CoBF response (peak), the delay or latency from the begin-
ning of drug application to the peak CoBF, and the post-CSD
hyperemic wave were determined by calculating the average
CoBF change in the 60–360th seconds after the peak. The
dose-dependent effects of the different stimulations were
statistically compared between the ZO and ZL groups with
two-way measures ANOVA or two-way repeated measures
ANOVA, accordingly, followed by the Tukey post-hoc test
(Sigmastat 3.5; Systat Software Inc., San Jose, CA, USA). To
compare the incidence of CSD triggered by NMDA, we
performed the z-test.
Experimental Protocol
Before each topical stimulation, aCSF was superfused over
the window using the same rate (1 mL/min) as the consec-
utive drug application to make sure that washing of the
window did not change baseline flow. We did not find any
change in the laser-Doppler signal in any of the rats tested
during control aCSF superfusion (data not shown). The first
set of ZL (n = 9) and ZO (n = 9) animals were stimulated
with increasing doses of bradykinin (1–100 lM; Sigma–
Aldrich, St. Louis, MO, USA) topically on the brain surface.
After five minutes of baseline recording, the topical appli-
cation took four minutes, after which the window was
washed with 1 mL aCSF over a one-minute period. Then, the
next baseline was recorded. On the second set of ZL (n = 9)
and ZO (n = 9) animals, increasing doses (105–103 M) of
NMDA (Sigma–Aldrich) were administered onto the brain
surface for 10 minutes each.
In the third experimental group, following baseline
recording, 14 ZL and 13 ZO rats were ventilated with 5%
CO2 for five minutes. After hypercapnia, ventilation was
switched back to room air. After 20 minutes, the cranial
windows were superfused with 104 M, then with 5 9 104,
and finally with 103 M bicucilline-methiodide (Tocris
Bioscience, St. Louis, MO, USA), for 10 minutes for each
dose. The window was then washed every 10 minutes with
aCSF for one hour.
RESULTS
The topical application of bradykinin (Figure 1) dose-
dependently increased the CoBF in both the ZL and ZO
animals with 9 ± 2% and 11 ± 4% (1 lM), 21 ± 4% and
27 ± 6% (10 lM), and 42 ± 12% and 42 ± 10% (100 lM),
Figure 1. The effect of increasing doses of topical bradykinin (1, 10, and
100 lM) on CoBF change from baseline in ZL (black columns) and ZO
(white columns) rats. Data presented are the average of the 10th minute
of bradykinin application. Data are mean ± SEM; (n = 7–7; *p < 0.05;
1 lM vs. 10 lM and 1 lM vs. 100 lM).
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respectively. No significant difference was detected between
the two groups at any dose.
Although NMDA induced marked increases in CoBF,
these perfusion changes were confounded by NMDA-
induced CSDs. Thus, the typical response for topical NMDA
application consisted of a CSD-related, fast and large
hyperemic response followed by a milder, but more
sustained, CoBF increase (Figure 2A and B). We identified
a CoBF response to NMDA as CSD-induced if it was
accompanied by a negative DC-potential shift and a similar
CoBF response was recorded after appropriate delay under
the second, frontal laser Doppler probe outside the cranial
window during the stimulation period (10 minutes). Six of
nine rats had CSD responses in both the ZL and the ZO
groups for the lower (104 M) dose of NMDA, while all ZL
and ZO rats (9/9) showed CSD with the 103 M dose of
NMDA. To compare the responses of the different NMDA
doses, only animals in which CSD was evoked by both
NMDA doses (n = 6–6) were included in the statistical
analysis. The latency of CSD peak appearance (Figure 2C)
was significantly shorter for the higher vs. the lower dose of
NMDA in both groups (p < 0.05), but was not different in
the ZO group both at 104 M (158 ± 8 s) and at 103 M
(118 ± 4 s) NMDA from the ZL (177 ± 15 and 122 ± 13 s)
counterpart. The peak amplitude during the CSD response
(Figure 2D) was higher in response to the 103 M NMDA
(ZL = 176 ± 34%; ZO = 242 ± 21%) in comparison with
the 104 M NMDA (ZL = 110 ± 29%; ZO = 182 ± 12%;
p < 0.01), but again, no significant difference was found at
any dose between the ZO and ZL groups (p > 0.08).
Although the magnitude of the post-CSD hyperemia (Fig-
ure 2E) was significantly higher by 103 M NMDA
(ZL = 75 ± 18%; ZO = 60 ± 11%) than by the 104 M
NMDA, the degree of flow increase (ZL = 23 ± 12%;
ZO = 19 ± 8%; p < 0.05) in both the ZL and ZO rats was
similar.
Ventilation with 5% CO2 for five minutes caused mild
(ZL: pH = 7.28 ± 0.01, pCO2 = 47 ± 4 mmHg; ZO:
pH =7.31 ±0.02, pCO2 = 46 ± 4 mmHg) hypercapnia in
both groups compared with baseline blood gas values (ZL:
pH=7.42 ± 0.01, pCO2 = 36 ± 3 mmHg; ZO:
pH = 7.42 ± 0.02, pCO2 = 36 ± 1 mmHg; mean ± SD),
which were similar in the ZL and the ZO rats. During
hypercapnia, the CoBF increase to 5% CO2 ventilation
(Figure 3) after five minutes was 20 ± 4% in the ZL and
22 ± 3% in the ZO. Thus, we did not find any statistical
difference between the ZL and ZO groups.
Bicuculline administration onto the brain surface resulted
in cortical seizure activity detected by EEG (Figure 4A),
which was coupled with a time- and dose-dependent rise in
CoBF (Figure 4B), showing 30 ± 10% in ZL and 36 ± 15%
in ZO rats at 104 M dose, 66 ± 11% in the ZL and
68 ± 18% in the ZO at 5 9 104 M dose, and 95 ± 12% for
the ZL vs. 88 ± 19% in the ZO group by the 10th minute of
drug administration (p < 0.05). Similarly, the values of the
ZL and ZO groups were not statistically different.
A B
C D E
Figure 2. The CoBF response curves to 104 M NMDA (A) and to 103 M NMDA (B) in ZO (n = 5; gray curves) and ZL (n = 6) rats (black curves)
represented by LDF changes. (C) The latency to CoBF-peak was expressed in seconds, (D) peak amplitude, and (E) the average of post-peak sustained
hyperemia (from one minute post-peak for five minutes) following NMDA application were expressed as percentage increase from a five-minute baseline
period. Black column: ZL; white column: ZO. The CoBF data are presented as mean ± SEM and analyzed with two-way repeated measures analysis of
variance (n = 5–6, *p < 0.05 for NMDA 104 M dose vs. NMDA 103 M dose).
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DISCUSSION
The most important finding of our study is that microvas-
cular reactivity of the cerebrocortical microcirculation is
intact after exposure to multiple complex stimuli in IR but
not yet diabetic ZO rats. The assessed vascular stimuli
consisted of mild physiologic changes (such as CO2 sensi-
tivity; Figure 3) and more severe challenges (CSD, seizures;
Figures 2 and 4) in which the appropriate reaction of the
microvasculature is crucial to prevent cortical tissue injury.
Therefore, in contrast to the large cerebral arteries, the
responses of the microcirculatory system in the brain are
intact during the early phase of IR.
In this study, we first examined the vasoactive effect of
bradykinin, a peptide mediating inflammation-related hyper-
emia [39,43]. Bradykinin is produced in high amounts
during brain injury and inflammation. It directly dilates
major cerebral [14] and pial arterioles [6] and also indirectly
by releasing vasoactive glutamate from astrocytes [39]. The
mechanism of bradykinin-mediated dilation in cerebral
arterioles involves endothelial NO produced by eNOS and
COX-1-produced ROS [6,45,51,53,61], which activate KCa
channels on the surface of smooth muscle cells [53].
Previously, we found that dilation of the middle cerebral
artery to bradykinin is reduced in fructose-fed IR rats [14].
In contrast, our current data (Figure 1) show that the
dilation of arterioles to bradykinin is preserved in ZO rats,
suggesting that dilatory pathways, which involve eNOS,
COX-1, ROS, and KCa channel, are not functionally impaired
or that different compensatory pathways are activated at the
level of microcirculation in IR.
Our second purpose was to explore the characteristics of
NMDA-induced CoBF changes. NMDA is a potent in vivo
dilator of cerebrocortical microvessels through a unique
neuro-vascular mechanism [7]. More recently, NMDA has
been shown to generate CSD in the mouse [2]. We recently
showed that NMDA-induced cortical hyperemia is induced
by CSD-dependent and -independent mechanisms in the rat
cortex [37]. CSD is a wave of depolarization, which
propagates over the cortical surface accompanied by a
sudden increase in tissue perfusion. It is associated with
migraine attacks, and it exaggerates stroke following ischemic
and/or hemorrhagic stroke [12,23,36]. In this study, NMDA
application onto the brain surface of ZO and ZL rats
produced a dose-dependent CoBF elevation, starting with a
CSD-related peak hyperemia followed by a prolonged
hyperemic phase (Figure 2), which is in accordance with
our previous finding in Wistar rats [37]. The mechanism of
NMDA-mediated CoBF response involves multiple cells and
signaling pathways [7,50]. In the rat cortex, the CSD-induced
cerebrovascular response is resistant to the non-selective
NOS blocker, L-NAME [20,52]. On the other hand,
the NMDA-induced-, presumably CSD-independent, corti-
cal vasodilation [3,22] and hyperemic [60] response were
abolished by the selective neuronal NOS inhibitor
7-nitroindazole. NMDA-induced neuronal NO release and
vasodilation seem to be an astroglia and endothelium-
independent process [4,11,21], and it presumably activates
KATP channels and KCa channels on the vascular smooth
muscle surface [47]. Our earlier experiments on the basilar
artery in vivo and on the isolated middle cerebral artery
clearly showed that KCa- and KATP-channel-mediated dila-
tions are significantly reduced in fructose-fed IR rats as well
as in ZO rats [15,17,18,32]. Importantly, these vascular
dysfunctions were reversed with antioxidant enzymes [15,17]
and protein kinase C antagonists [17]. This study shows that
neither the CSD-related, nor the sustained post-CSD hyper-
emia deteriorated in the cortex of IR rats.
Third, we studied the effect of topical bicuculline appli-
cation on CoBF (Figure 4). Our findings confirm that
bicuculline elevates tissue perfusion [40] as a surrogate of
increased neuronal firing rate [41]. The seizure-induced
CoBF response is complex and is related to the compound
effects of local tissue acidosis [29,38], elevated extracellular
K+ [24,35], and adenosine levels [5] released from astrocytes
and activated neurons [1,42]. The dilation of the basilar
artery to high extracellular K+ levels was shown to be reduced
in IR [17]. The similar dose-dependent CoBF response of ZO
and ZL strains to bicuculline in addition to NMDA further
confirms the hypothesis that neuronal activity-coupled
hemodynamic responses are indeed preserved in IR.
To our knowledge, our study is the first to investigate the
CO2 response of the cerebral circulation in IR. We found that
the CO2 response to 5% CO2 of IR rats remained unchanged
(Figure 3), which suggests simultaneous intact reactivity of
the microvasculature. Hypercapnic hyperemia is induced by
extraluminal acidosis and is mediated by NO [19,30,31],
prostaglandins [27], and adenosine [19,49], factors which
relax the smooth muscle cells via KCa and KATP channels
[38]. Previous studies have shown that cerebral vascular
Figure 3. Temporal changes of CoBF during five minutes of 5% CO2
ventilation (n = 12–14) in ZO (white column) and ZL (black column) rats.
The CoBF data are presented as mean ± SEM and analyzed with two-way
repeated measures analysis of variance.
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dilation to hypercapnia occurs primarily in the small cerebral
arteries, while dilation of larger arteries is restricted by
activation of sympathetic nerves [58]. Our finding is in
concert with human studies where the cerebrovascular
reactivity after acetazolamide stimulation (inducing local
hypercapnia and acidosis) was reduced in long-term
(>10 years) diabetic patients, but not in short-term
(<10 years) diabetic patients [25].
LDF has several advantages over other methods for
characterizing cerebral hemodynamics including ease of
application, the ability to continuously monitor CoBF during
changing conditions in the same animal, and a history of
extensive use and validation under a variety of experimental
conditions. Nonetheless, potential drawbacks are that abso-
lute CoBF values cannot be determined and that the LDF
might not be sensitive enough to detect differences in CoBF
responses between ZO and ZL animals because of the limited
depth of penetration of the laser light and because of the
restricted area of the cortex that is examined by the probe.
On the other hand, other in vivo methods for measuring
CoBF also have serious drawbacks that make the interpre-
tation of results difficult. For example, the microsphere
method necessitates the permanent occlusion of one carotid
artery for placement of the intracardiac catheter for injection
of the microspheres, which restricts increases in blood flow
to both cortices. Similarly, the use of diffusible tracers such as
C14 iodoantipyrine is technically difficult because of repeated
withdrawal of significant amounts of blood, and allows only
one CoBF measurement in each animal so that repeated
determinations are not possible in each animal. Thus, we are
cautious in our conclusions until the results can be validated
with another, independent approach, such as multi-photon
microscopy. Furthermore, we cannot assert that CoBF
responses to other stimuli or conditions would be similarly
unaffected by IR.
PERSPECTIVE
In summary, on the basis of our findings, we suggest that the
deleterious effect of IR in the pre-diabetic stage is limited to
the major cerebral vessels, and that the local control of
cerebrocortical microcirculation is preserved in response to
the robust stimuli employed in our study. These findings
replicate earlier findings in dogs in which fixation of the
surface arteries by cyanoacrylate glue did not reduce
increases in CoBF to hypercapnia [8]. Previous studies
showed reversible dysfunction of major cerebral arteries at
this level of IR in the same animal model.
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